The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses
Published version of a preprint
Abstract
Objectives: Genital herpes simplex virus (HSV) type 1 and 2 infections are lifelong and can cause symptomatic genital ulcer disease (GUD). HSV-2 almost always causes sexually transmitted genital infection, while HSV-1 mainly causes oral infection but can be sexually transmitted to cause genital infection. This study estimated genital infection with both HSV types and associated GUD globally in 2020, breaking down the data by WHO region and sex for females and males. Methods: A calibrated mathematical model was employed to generate estimates for the incidence and prevalence of HSV-2 infection, genital HSV-1 infection, and GUD caused by both HSV types. Estimates for non-genital infections caused by HSV-1 were also generated. Model input was derived from a comprehensive systematic review and meta-analyses of HSV prevalence data for all WHO regions. Results: Globally in 2020 there were 25.6 million (95% uncertainty interval (UI) 23.1–29.4 million) people aged 15–49 years with new HSV-2 infections, and 519.5 million (95% UI 464.3–611.3 million), or 13.3% (95% UI 11.9–15.6%), with existing (prevalent) HSV-2 infections. In addition, there were 16.8 million (95% UI 10.6–22.4 million) people aged 15–49 years with new genital HSV-1 infections and 376.2 million (95% UI 235.6–483.5 million), or 10.2% (95% UI 6.4–13.1%), with prevalent genital HSV-1 infections. The estimated number of people aged 15–49 years with at least one episode of HSV-attributable GUD in 2020 was 187.9 million (95% UI 116.0–291.8 million) for HSV-2, and 16.7 million (95% UI 9.3–25.2 million) for HSV-1, totalling 204.6 million (95% UI 132.3–306.5 million). Conclusion: Genital HSV infections have a high incidence and prevalence worldwide, contributing to a significant GUD disease burden. New prevention and treatment measures, such as prophylactic and therapeutic HSV vaccines, are needed critically to control HSV infections and reduce the associated disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For this reason, the WHO has emphasized the need for integrated surveillance and the development of prophylactic and therapeutic vaccines against HSV-2 [18].”
From Primary Genital HSV-2 Infection in a Resource-Limited Setting: Diagnostic Challenges and Clinical Implications (2025) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016
Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L. J., Chico, R. M., Smolak, A., Newman, L., Gottlieb, S., et al. (2019) · Bulletin of the World Health Organization · doi:10.2471/blt.18.228486 · Cited by 1,665
Self-citation
Research works printed but not linked: 70
- 10.2471/BLT.19.237149 · DOI · Paper page
- Looker, 2020, The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study, BMJ Glob Health, 5, 10.1136/bmjgh-2019-001875 · DOI
- Silva, 2022, Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low- and middle-income countries: a modeling study, PLoS Med, 19, 10.1371/journal.pmed.1003938 · DOI
- 10.1001/jama.2022.19061 · doi:10.1001/jama.2022.19061
- 10.1001/jama.2011.420 · DOI · Paper page
- 10.1097/OLQ.0000000000000522 · DOI
- 10.1086/591913 · DOI · Paper page
- Schiffer, 2009, Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model, Sci Transl Med, 1, 10.1126/scitranslmed.3000193 · DOI
- 10.1097/OLQ.0000000000001612 · doi:10.1097/olq.0000000000001612
- AlMukdad, 2021, Epidemiology of herpes simplex virus type 2 in Asia: a systematic review, meta-analysis, and meta-regression, Lancet Reg Health - West Pac, 12, 100176
- Harfouche, 2021, Epidemiology of herpes simplex virus type 2 in sub-Saharan Africa: systematic review, meta-analyses, and meta-regressions, EClinMed, 35
- 10.1136/sextrans-2021-054972 · DOI
- 10.1136/sti.2004.011619 · DOI
- 10.1016/S0140-6736(07)61908-4 · DOI · Paper page
- 10.1111/j.1552-6909.2009.01026.x · DOI
- 10.2165/00023210-200519040-00003 · DOI
- 10.1016/S1473-3099(17)30405-X · DOI · Paper page
- Abu-Raddad, 2008, Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa, PLoS One, 3, 10.1371/journal.pone.0002230 · DOI · Paper page
- 10.1016/S1473-3099(19)30470-0 · DOI
- 10.1136/sextrans-2017-053336 · DOI
- Higgins, 1993, Natural history, management and complications of herpes labialis, J Med Virol, Suppl 1, 22, 10.1002/jmv.1890410506 · doi:10.1002/jmv.1890410506
- 10.1111/odi.13234 · DOI
- 10.1016/j.antiviral.2003.09.006 · DOI · Paper page
- 10.1016/j.jaad.2007.06.027 · DOI · Paper page
- Whitley, 2018, Clinical management of herpes simplex virus infections: past, present, and future, F1000Res, 7, 10.12688/f1000research.16157.1 · DOI · Paper page
- Ayoub, 2019, Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions, BMC Med, 17, 10.1186/s12916-019-1285-x · DOI
- AlMukdad, 2023, Epidemiology of herpes simplex virus type 1 in Canada: systematic review, meta-analyses, and meta-regressions, Front Public Health, 11, 10.3389/fpubh.2023.1118249 · DOI
- Yousuf, 2020, Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions, BMJ Glob Health, 5, 10.1136/bmjgh-2020-002388 · DOI
- 10.1055/s-0032-1332802 · DOI
- 10.1016/S2214-109X(16)30362-X · DOI · Paper page
- 10.1016/j.vaccine.2016.03.111 · DOI
- Looker, 2015, Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012, PLoS One, 10, 10.1371/journal.pone.0140765 · DOI · Paper page
- Looker, 2015, Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012, PLoS One, 10, 10.1371/journal.pone.0114989 · DOI · Paper page
- Alareeki, 2023, Epidemiology of herpes simplex virus type 2 in Europe: systematic review, meta-analyses, and meta-regressions, Lancet Reg Health Eur, 25, 10.1016/j.lanepe.2022.100558 · DOI
- AlMukdad, 2023, Epidemiology of herpes simplex virus type 1 and genital herpes in Australia and New Zealand: systematic review, meta-analyses and meta-regressions, Epidemiol Infect, 151, 10.1017/S0950268823000183 · DOI
- Chaabane, 2019, Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions, Sci Rep, 9, 10.1038/s41598-018-37833-8 · DOI
- Harfouche, 2023, Epidemiology of herpes simplex virus type 2 in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions, J Med Virol, 95, 10.1002/jmv.28603 · DOI
- 10.1016/j.jinf.2019.07.012 · DOI
- 10.1093/cid/ciy562 · DOI
- Sukik, 2019, Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: systematic review and meta-analytics, PLoS One, 14, 10.1371/journal.pone.0215487 · DOI
- Ashley, 2002, Performance and use of HSV type-specific serology test kits, Herpes, 9, 38
- 10.1111/j.1469-0691.2004.00836.x · DOI
- 10.7326/0003-4819-115-7-520 · DOI
- 10.1136/sti.77.4.232 · DOI · Paper page
- 10.1016/j.jcv.2019.01.001 · doi:10.1016/j.jcv.2019.01.001
- 10.1136/sti.2009.036541 · DOI
- 10.1001/jama.2016.17138 · DOI
- 10.1128/JCM.40.2.407-413.2002 · DOI
- 10.1097/OLQ.0000000000000791 · doi:10.1097/olq.0000000000000791
- Borenstein M , Hedges LV , Higgins JPT , et al . Introduction to meta-analysis. Chichester, UK: John Wiley & Sons, Ltd, 2011.
- 10.1214/aoms/1177729756 · DOI · Paper page
- Schwarzer, 2007, Meta: an R package for meta-analysis, R news, 7, 40
- 10.1016/S0140-6736(16)30388-9 · DOI · Paper page
- Ayoub, 2021, Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950-2050, Open Forum Infect Dis, 8, 10.1093/ofid/ofab218 · doi:10.1093/ofid/ofab218
- 10.1016/j.epidem.2009.03.001 · DOI
- Hallett, 2006, Declines in HIV prevalence can be associated with changing sexual behaviour in Uganda, urban Kenya, Zimbabwe, and urban Haiti, Sex Transm Infect, 82 Suppl 1, i1, 10.1136/sti.2005.016014 · DOI · Paper page
- 10.1097/00002030-199902250-00012 · DOI · Paper page
- 10.1016/j.epidem.2014.06.001 · doi:10.1016/j.epidem.2014.06.001
- 10.3109/13625181003797280 · DOI
- 10.1016/S2214-109X(16)30135-8 · DOI · Paper page
- 10.1093/cid/cis891 · DOI · Paper page
- 10.1093/cid/cis894 · doi:10.1093/cid/cis894
- 10.1056/NEJM199708213370801 · DOI · Paper page
- 10.1056/NEJM199911043411904 · DOI · Paper page
- 10.1093/infdis/161.4.653 · DOI
- 10.1097/OLQ.0b013e3181c04dea · DOI
- 10.1128/CMR.00043-15 · DOI · Paper page
- 10.1016/j.vaccine.2017.03.074 · DOI
- 10.1016/j.vaccine.2017.10.084 · doi:10.1016/j.vaccine.2017.10.084
- Ayoub, 2020, Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses, Vaccines (Basel), 8, 10.3390/vaccines8030366 · DOI
Cited by
Maksud, R. O., Antuke, N. R. P. P., & Qurrohman, T. (2025) · Cureus · doi:10.7759/cureus.95820 · Cited by 1
Metadata
- Authors
- Harfouche, M., AlMukdad, S., Alareeki, A., Osman, A. M. M., Gottlieb, S., Rowley, J., Abu-Raddad, L. J., & Looker, K. J.
- ORCID
- Abu-Raddad, Laith J
- Venue
- Sexually Transmitted Infections
- Publisher
- BMJ
- Published
- 2024-12-10
- Volume
- 101
- Issue
- 4
- Pages
- 214-223
- ISSN
- 1368-4973
- 1472-3263
- Cited by
- 110
- References
- 1
- Language
- en
- Funders
- University of Bristol (Health Protection Research Unit (HPRU) in Behaviou, National Institute for Health Research (NIHR))
- Qatar National Research Fund (NPRP9-040-3-008)
- Weill Cornell Medicine - Qatar (Biomedical Research Program, Biostatistics, Epidemiology, and the Biomathematic)
- UK Health Security Agency (N/A)
- Qatar Research, Development, and Innovation Council (ARG01-0524-230321)
- United States Agency for International Development (World Health Organization (Global HIV, Hepatitis a)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. https://app.cochat.ai/papers/10.1136/sextrans-2024-056307
- The paper
- Harfouche, M., AlMukdad, S., Alareeki, A., Osman, A. M. M., Gottlieb, S., Rowley, J., Abu-Raddad, L. J., & Looker, K. J. (2025). Estimated global and regional incidence and prevalence of herpes simplex virus infections and genital ulcer disease in 2020: mathematical modelling analyses. Sexually Transmitted Infections. https://doi.org/10.1136/sextrans-2024-056307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.